Literature DB >> 15591050

Agonist-mediated conformational changes in acetylcholine-binding protein revealed by simulation and intrinsic tryptophan fluorescence.

Fan Gao1, Nina Bren, Thomas P Burghardt, Scott Hansen, Richard H Henchman, Palmer Taylor, J Andrew McCammon, Steven M Sine.   

Abstract

We delineated acetylcholine (ACh)-dependent conformational changes in a prototype of the nicotinic receptor ligand binding domain by molecular dynamics simulation and changes in intrinsic tryptophan (Trp) fluorescence. Prolonged molecular dynamics simulation of ACh-binding protein showed that binding of ACh establishes close register of Trps from adjacent subunits, Trp(143) and Trp(53), and draws the peripheral C-loop inward to occlude the entrance to the binding cavity. Close register of Trp(143) and Trp(53) was demonstrated by ACh-mediated quenching of intrinsic Trp fluorescence, elimination of quenching by mutation of one or both Trps to Phe, and decreased lifetime of Trp fluorescence by bound ACh. Occlusion of the binding cavity by the C-loop was demonstrated by restricted access of an extrinsic quencher of binding site Trp fluorescence by ACh. The collective findings showed that ACh initially establishes close register of conserved Trps from adjacent subunits and then draws the C-loop inward to occlude the entrance to the binding cavity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15591050     DOI: 10.1074/jbc.M412389200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  Enhanced meta-analysis of acetylcholine binding protein structures reveals conformational signatures of agonism in nicotinic receptors.

Authors:  Spencer T Stober; Cameron F Abrams
Journal:  Protein Sci       Date:  2012-03       Impact factor: 6.725

2.  Structural link between γ-aminobutyric acid type A (GABAA) receptor agonist binding site and inner β-sheet governs channel activation and allosteric drug modulation.

Authors:  Srinivasan P Venkatachalan; Cynthia Czajkowski
Journal:  J Biol Chem       Date:  2012-01-04       Impact factor: 5.157

3.  Myasthenic syndrome AChRα C-loop mutant disrupts initiation of channel gating.

Authors:  Xin-Ming Shen; Joan M Brengman; Steven M Sine; Andrew G Engel
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

4.  Creating an α7 nicotinic acetylcholine recognition domain from the acetylcholine-binding protein: crystallographic and ligand selectivity analyses.

Authors:  Akos Nemecz; Palmer Taylor
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

5.  A gating mechanism proposed from a simulation of a human alpha7 nicotinic acetylcholine receptor.

Authors:  Richard J Law; Richard H Henchman; J Andrew McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-27       Impact factor: 11.205

6.  Chemical-scale studies on the role of a conserved aspartate in preorganizing the agonist binding site of the nicotinic acetylcholine receptor.

Authors:  Amanda L Cashin; Michael M Torrice; Kathryn A McMenimen; Henry A Lester; Dennis A Dougherty
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

Review 7.  Inside-out neuropharmacology of nicotinic drugs.

Authors:  Brandon J Henderson; Henry A Lester
Journal:  Neuropharmacology       Date:  2015-02-04       Impact factor: 5.250

8.  Allosteric modulators induce distinct movements at the GABA-binding site interface of the GABA-A receptor.

Authors:  Feyza Sancar; Cynthia Czajkowski
Journal:  Neuropharmacology       Date:  2010-11-18       Impact factor: 5.250

9.  The kinetics of competitive antagonism of nicotinic acetylcholine receptors at physiological temperature.

Authors:  Deeptankar Demazumder; James P Dilger
Journal:  J Physiol       Date:  2007-12-06       Impact factor: 5.182

10.  Amino acid residues that confer high selectivity of the alpha6 nicotinic acetylcholine receptor subunit to alpha-conotoxin MII[S4A,E11A,L15A].

Authors:  Layla Azam; Doju Yoshikami; J Michael McIntosh
Journal:  J Biol Chem       Date:  2008-02-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.